Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: 17 - The Untold Story

Bank of Nova Scotia Q2 Earnings Call Highlights

Bank of Nova Scotia (NYSE:BNS) reported stronger second-quarter fiscal 2026 results, with management pointing to revenue growth, expense discipline and rising returns across several business lines while also acknowledging a more uncertain credit backdrop. President and Chief Executive Officer Scott

MarketBeat

HICL Infrastructure H2 Earnings Call Highlights

HICL Infrastructure (LON:HICL) said its annual results were supported by strong operational performance, accretive asset sales and improved cash generation, as the infrastructure investment company outlined a higher dividend target and continued focus on disciplined capital allocation. During the a

MarketBeat

PDD Q1 Earnings Call Highlights

PDD (NASDAQ:PDD) Holdings reported first-quarter 2026 revenue of RMB 106.2 billion, up 11% from a year earlier, as management emphasized a multiyear push to deepen supply chain investments and expand a new first-party brand business. On the company’s earnings call, Co-Chairman and Co-Chief Executiv

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

What Investors Need to Know About TSMC's Hefty 17% Dividend Increase

See what TSMC's dividend yield looks like after its latest increase, and the wrinkles in this company's dividend profile investors cannot overlook.

MarketBeat

Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance

Mirum Pharmaceuticals (NASDAQ:MIRM) executives said the rare disease company is entering a catalyst-heavy period, with recent positive clinical updates, ongoing commercial momentum for LIVMARLI and additional business development activity expanding its portfolio. Speaking at RBC Capital Markets’ 20

MarketBeat

Hafnia Q1 Earnings Call Highlights

Hafnia (NYSE:HAFN) reported a sharply higher first-quarter 2026 profit as management said geopolitical disruption and tighter tanker availability drove freight rates higher across the product tanker market. Chief Executive Officer Mikael Skov said the quarter was “transformative” for the tanker ind

MarketBeat

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates

MacroGenics (NASDAQ:MGNX) Chief Executive Officer Eric Risser said the biotechnology company has strengthened its balance sheet through two recent transactions while preparing for a series of clinical updates across its oncology pipeline. Speaking during an informal discussion hosted by Stifel seni

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Aroundtown Q1 Earnings Call Highlights

Aroundtown (ETR:AT1) reported higher first-quarter rental income and lifted its 2026 absolute FFO guidance after increasing its stake in Grand City Properties, while management said the company remains focused on capital recycling, conversions and balance-sheet flexibility amid a volatile macroecono

MarketBeat

Microchip Technology Sees Demand Rebound, Margin Gains as Bookings Hit 4-Year High

Microchip Technology (NASDAQ:MCHP) is seeing a broad-based recovery in demand and expects continued margin improvement as it ramps production and works down remaining underutilization costs, Chief Financial Officer Eric Bjornholt said at JPMorgan’s 54th Annual Technology and Media Communications Con

MarketBeat

Greencore Group H1 Earnings Call Highlights

Greencore Group (LON:GNC) said its enlarged U.K. convenience foods business delivered higher first-half revenue and profit following the acquisition of Bakkavor UK, while management said integration work is progressing without disruption to service levels or customer relationships. Presenting the c

MarketBeat

Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline Advances

Lyell Immunopharma (NASDAQ:LYEL) President and CEO Lynn Seely outlined the company’s clinical development priorities, regulatory strategy and manufacturing plans during a Stifel investor session moderated by Stephen Willey, senior biotech analyst at Stifel. Seely described Lyell as a cell therapy c

MarketBeat

Pets at Home Group H2 Earnings Call Highlights

Pets at Home Group (LON:PETS) executives said the company is seeing early signs of momentum from its retail turnaround plan, while cautioning that the veterinary business is likely to see more subdued revenue growth in the near term before improving as the pandemic-era pet cohort ages. Speaking on

MarketBeat

Logitech International CEO Eyes AI, B2B Growth as Next Investment Push Begins

Logitech International (NASDAQ:LOGI) Chief Executive Hanneke Faber said the company is entering its next phase from a position of financial strength, with plans to increase investment in innovation, business-to-business sales and marketing while keeping margins near the high end of its long-term mod

MarketBeat

Qfin Q1 Earnings Call Highlights

Qfin (NASDAQ:QFIN) reported lower first-quarter 2026 revenue and profit as management described continued pressure across China’s consumer credit market, but said recent risk-control measures are beginning to show results. CEO Haisheng Wu said China’s consumer credit industry has been undergoing “p

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Agora Q1 Earnings Call Highlights

Agora (NASDAQ:API) reported first-quarter 2026 revenue above its guidance range and posted its sixth consecutive quarter of GAAP profitability, as management pointed to continued growth in real-time engagement services and rising demand for conversational AI products. Founder, Chairman and CEO Tony

MarketBeat

IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit

IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress across the company’s oncology pipeline during a fireside chat at TD Cowen’s seventh annual Oncology Innovation Summit, with the discussion focused primarily on darovasertib combinations in uveal melanoma and several ear

MarketBeat

BOX Q1 Earnings Call Highlights

BOX (NYSE:BOX) reported a stronger-than-expected start to fiscal 2027, with management pointing to growing adoption of its Enterprise Advanced offering and AI-driven content workflow products as key drivers of its results. On the company’s first-quarter earnings call, Box Co-founder and CFO Dylan S

MarketBeat

Ooma Q1 Earnings Call Highlights

Ooma (NYSE:OOMA) reported a stronger-than-expected start to fiscal 2027, with management citing growth in its business communications segment, accelerating adoption of its AirDial POTS replacement product and contributions from recent acquisitions. CEO Eric Stang said the company exceeded expectati

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Semtech Q1 Earnings Call Highlights

Semtech (NASDAQ:SMTC) reported record quarterly revenue for its first quarter of fiscal 2027, driven by strength in its data center and LoRa businesses, and issued a second-quarter outlook that calls for continued acceleration across its major segments. President and Chief Executive Officer Hong Ho

MarketBeat

Zscaler Q3 Earnings Call Highlights

Zscaler (NASDAQ:ZS) reported stronger-than-expected fiscal third-quarter results, with management highlighting growth in annual recurring revenue, record operating margin and rising demand for its zero-trust security platform as enterprises adopt artificial intelligence tools. Chairman and CEO Jay

MarketBeat

Transcat Q4 Earnings Call Highlights

Transcat (NASDAQ:TRNS) reported double-digit revenue growth in both of its business segments for the fiscal fourth quarter, as newly appointed President and CEO Jaime Irick told investors the company plans to continue emphasizing organic service growth, margin expansion, acquisitions and rentals. O

MarketBeat

Digital Turbine Q4 Earnings Call Highlights

Digital Turbine (NASDAQ:APPS) reported fourth-quarter and fiscal 2026 results that exceeded management’s expectations, with executives pointing to growth in its on-device business, a sharp acceleration in its app growth platform and increased use of artificial intelligence across the company’s opera

MarketBeat

3 Defense Giants Boosting Dividends as Shares Take a Ride

Northrop Grumman and two other large defense stocks just announced significant increases to their dividends as shares swing in 2026.

MarketBeat

Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026

Williams-Sonoma's stock price is on track to set a fresh high as the company outperforms, produces profits, and returns capital to investors.

MarketBeat

EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears

Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP-1901, beginning in August, with a second pivotal trial expected to follow about two months later.

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.